Back to search
Cerebral Microbleeds
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cerebral Microbleeds trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Cerebral Microbleeds trials you may qualify forThe purpose of this prospective cohort study is to investigate whether antithrombotic therapy in the secondary prevention of ischemic stroke increases the risk…
To observe the effect of different antithrombotic drugs on the prognosis of ischemic stroke patients with cerebral microbleeds. And further combined with proteo…
The purpose of this clinical trial is to demonstrate that cilostazol is non-inferior to aspirin in terms of efficacy and safety for the secondary prevention of…
Oral bacteria constitute the second largest population of the human microbiome. Recent studies have identified their role in the development of systemic disease…
Cerebral microbleeds (CMBs) are haemosiderin deposits, resulting from the leakage of erythrocytes from small cerebral vessels, which can be detected noninvasive…
The investigators continuously collected data from 482 AIS inpatients at the Neurology Department of Hebei General Hospital. Both demographic and clinical data…